Trials / Terminated
TerminatedNCT05327361
LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)
Evaluation of the Depigmenting Effect of Liftactiv B3 Serum (Split Face) in Patients With Mild to Moderate Facial Post-acne PIHP for 3 Months
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to measure the depigmenting effect of a serum product called Liftactiv B3 in patients with mild to moderate facial PIHP (Post Inflammatory Hyper Pigmentation)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Liftactiv B3 | Participants will apply a dime size amount of the serum to 1 side of the face. |
| OTHER | Sunscreen | Participants will apply a dime size amount of sunscreen to cover the other half of the face. |
Timeline
- Start date
- 2022-03-22
- Primary completion
- 2023-01-17
- Completion
- 2023-03-06
- First posted
- 2022-04-14
- Last updated
- 2024-04-03
- Results posted
- 2024-04-03
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05327361. Inclusion in this directory is not an endorsement.